Relugolix |
Isotretinoin EP Impurity G |
VE009951 | View CAS 81444-57-7 |
Relugolix |
Relugolix Impurity 10 |
VE009949 | View |
Relugolix |
Relugolix Impurity 20 |
VE009944 | View |
Relugolix |
Relugolix Impurity 23 |
VE009945 | View |
Relugolix |
Relugolix Impurity 24 |
VE009946 | View |
Relugolix |
Relugolix Impurity 25 |
VE009947 | View |
Relugolix |
Relugolix Impurity 27 |
VE009948 | View |
Relugolix |
Relugolix Impurity V |
VE0010586 | View |
Relugolix |
1-(4-(1-(2, 6-difluorobenzyl)-5-((dimethylamino)methyl)-3-(6-methoxypyridazin-3-yl)-2, 4-dioxo-1, 2, 3, 4-tetrahydrothieno[2, 3-d]pyrimidin-6-yl)phenyl)urea |
VE0010585 | View |
Relugolix |
2-((2, 6-difluorobenzyl)amino)-4-((dimethylamino)methyl)-N-(6-methoxypyridazin-3-yl)-5-(4-(3-methoxyureido)phenyl)thiophene-3-carboxamide |
VE0010584 | View |
Relugolix |
6-(4-Aminophenyl)-1-(2, 6-difluorobenzyl)-5-((dimethylamino)methyl)-3-(6-methoxypyridazin-3-yl)thieno[2, 3-d]pyrimidine-2, 4(1H, 3H)-dione |
VE0010583 | View CAS 1589503-93-4 |